The traditional healthcare system offered a reactive model: when you fall ill, you visit a…
TechPharus
Latest Posts
Blueprint for Tomorrow: Abu Dhabi’s Genomic Vision for Healthcare
Abu Dhabi is leading a genomic revolution that promises to reshape healthcare by deeply understanding…
The UAE’s Expanding Life Sciences Ecosystem: A New Global Powerhouse
The UAE’s healthcare and life-science sector is experiencing rapid growth, powered by a robust ecosystem…
Building the Future of Pharma: Abu Dhabi’s Strategic Leap
Abu Dhabi’s Pharmaceutical Sector: Rising to Global Prominence Over the past decade, Abu Dhabi—one of…
How the UAE is Shaping the Future of Longevity and Healthspan
The United Arab Emirates is swiftly positioning itself as a global leader in the Longevity…
Interview with Dr. Priyanka Mathur, MediPocket World
We recently spoke to Dr. Priyanka Mathur, a visionary healthcare leader with international healthcare experience…
HealthTech News
- Use of MRI before prostate biopsies increases sharply across U.S. hospitalson September 20, 2026 at 7:20 pm
Using prostate MRI before a biopsy is a real advance in prostate cancer diagnosis. Multiple randomized trials have shown that imaging the prostate first and then targeting suspicious lesions finds more of the aggressive cancers that matter. As a result, guidelines have progressively strengthened their recommendations for MRI.
- Activated donor immune cells may prevent severe complication after allogeneic stem cell transplantationon September 20, 2026 at 6:00 pm
Researchers have successfully conducted the first clinical trial using activated regulatory T cells (ATregs, Actileucel)—derived from white blood cells of healthy blood donors. This novel cell therapy aims to prevent graft-versus-host disease (GvHD) following an allogeneic stem cell transplant. The Phase I/II study has yielded extremely encouraging results: ATregs can be produced within 24 hours and injected immediately afterward; administration is safe and well-tolerated by patients—a significant step toward a widely available cell therapy. The research is published in Transplantation and Cellular Therapy.
- Salivary cortisol patterns linked to cognitive decline over 11 yearson September 20, 2026 at 3:40 pm
In a study published in the journal JAMA Network Open, an irregular pattern and consistently higher levels of the stress hormone cortisol in saliva were associated with cognitive decline later in life. Black participants specifically had lower overall cortisol levels and less change in their levels during the day than white participants, according to newly published research.
- Sharper reasoning skills in teen years tied to lower dementia risk later in lifeon September 20, 2026 at 1:00 pm
Could the way we think in our 20s offer clues about our risk of dementia decades later? Large population studies suggest that people who perform better on thinking ability tests in adolescence or young adulthood are less likely to develop dementia later in life. However, cognitive performance in early adulthood is shaped by more than thinking ability alone; it can also reflect education, life experiences and family environment. This makes it difficult to determine whether scores on cognitive tests are a reliable indicator of future dementia risk.
- One-third of older adults with cognitive disorders are taking prescription drugs that could harm themon September 20, 2026 at 12:00 pm
Adults 65 and older with cognitive disorders such as dementia are more likely to suffer negative effects from drugs that treat central nervous system conditions, including anxiety, sleep problems and psychosis. This means more emergency department visits, more frequent and longer hospitalizations, poorer mental health and a greater risk of premature death.




